Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Sunshine Lake Pharma Co., Ltd. Class H ( (HK:6887) ) has issued an update.
Sunshine Lake Pharma Co., Ltd. has announced its plan to implement the full circulation of its H shares. This involves converting 251,378,534 domestic shares into H shares, representing approximately 43.59% of the company’s total issued share capital. The conversion is subject to approvals from the China Securities Regulatory Commission and the Hong Kong Stock Exchange. This move is expected to enhance the company’s market presence and liquidity, potentially benefiting shareholders and investors.
More about Sunshine Lake Pharma Co., Ltd. Class H
Sunshine Lake Pharma Co., Ltd. is a pharmaceutical company based in the People’s Republic of China. The company is involved in the development, production, and distribution of pharmaceutical products, focusing on the domestic and international markets.
Average Trading Volume: 1,690,938
For detailed information about 6887 stock, go to TipRanks’ Stock Analysis page.